[1] Mou Y, Wang J, Wu J, et al.Ferroptosis, a new form of cell death: opportunities and challenges in cancer[J].J Hematol Oncol, 2019,12(1):34.
[2] Jiang X, Stockwell BR, Conrad M.Ferroptosis: mechanisms, biology and role in disease[J].Nat Rev Mol Cell Biol, 2021,22(4):266-282.
[3] 于放,马晶莹,马旺然,等.脂氧合酶在铁死亡驱动阿尔茨海默病中作用的研究进展[J].实用心脑肺血管病杂志,2022,30(12):128-132,136.
[4] Zhang C, Liu X, Jin S, et al.Ferroptosis in cancer therapy: a novel approach to reversing drug resistance[J].Mol Cancer, 2022,21(1):47.
[5] Wenzel SE, Tyurina YY, Zhao J, et al.PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals[J].Cell,2017,171(3):628-641.
[6] Zhao J, Dar HH, Deng Y, et al.PEBP1 acts as a rheostat between prosurvival autophagy and ferroptotic death in asthmatic epithelial cells[J].Proc Natl Acad Sci USA,2020,117(25):14376-14385.
[7] Manivarma T, Kapralov AA, Samovich SN, et al.Membrane regulation of 15LOX-1/PEBP1 complex prompts the generation of ferroptotic signals, oxygenated PEs[J].Free Radic Biol Med, 2023,208:458-467.
[8] Ou Y, Wang SJ, Li D, et al.Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses[J].ProcNatlAcad Sci USA, 2016,113(44):E6806-E6812.
[9] Shintoku R, Takigawa Y, Yamada K, et al.Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3[J].Cancer Sci, 2017,108(11):2187-2194.
[10] Harats D, Ben-Shushan D, Cohen H, et al.Inhibition of carcinogenesis in transgenic mouse models over-expressing 15-lipoxygenase in the vascular wall under the control of murine preproendothelin-1 promoter[J].Cancer Lett, 2005,229(1):127-134.
[11] Tavakoli Yaraki M, Karami Tehrani F.Apoptosis induced by 13-S-hydroxyoctadecadienoic acid in the breast cancer cell lines, MCF-7 and MDA-MB-231[J].Iran J Basic Med Sci, 2013,16(4):653-659.
[12] O'Flaherty JT, Wooten RE, Samuel MP, et al.Fatty acid metabolites in rapidly proliferating breast cancer[J].PLoS One, 2013,8(5):e63076.
[13] Kerjaschki D, Bago-Horvath Z, Rudas M, et al.Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse[J].J Clin Invest, 2011,121(5):2000-2012.
[14] Viola K, Kopf S, Huttary N, et al.Bay11-7082 inhibits the disintegration of the lymphendothelial barrier triggered by MCF-7 breast cancer spheroids; the role of ICAM-1 and adhesion[J].Br J Cancer, 2013,108(3):564-569.
[15] Wu X, Liu C, Li Z, et al.Regulation of GSK3β/Nrf2 signaling pathway modulated erastin-induced ferroptosis in breast cancer[J].Mol Cell Biochem, 2020,473(1-2):217-228.
[16] Li J, Wang W, Wang K, et al.Interleukin 13 participates in terminal differentiation of esophageal squamous cell carcinoma cells[J].J Gastrointest Oncol, 2022,13(4):1571-1578.
[17] Shureiqi I, Xu X, Chen D, et al.Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression[J].Cancer Res, 2001,61(12):4879-4884.
[18] 张瑜,李建生,李珍杰,等.15-脂氧合酶-1 mRNA、Podoplanin在食管鳞癌中的表达及临床意义[J].临床消化病杂志,2008,20(3):146-149.
[19] 王自有,王锐,赵耀伟,等.铁死亡机制在食管癌预后中的作用研究进展[J].现代医院,2023,23(11):1797-1800,1804.
[20] Wu J,Xia HH, Tu SP, et al.15-Lipoxygenase-1 mediates cyclooxygenase-2 inhibitor-induced apoptosis in gastric cancer[J].Carcinogenesis, 2003,24(2):243-247.
[21] 李勇,李建英,陈丰霖,等.15-脂氧合酶-1在胃癌中的表达及其临床意义[J].胃肠病学和肝病学杂志,2006,(6):576-580.
[22] 陈冬梅,林芬,李建英.15-脂氧合酶-1对胃癌细胞周期的影响及其机制研究[J].胃肠病学和肝病学杂志,2010,19(9):826-829.
[23] 林芬,李建英,陈丰霖,等.15-脂氧合酶-1在胃癌细胞AGS中的表达[J].福建医科大学学报,2009,43(1):23-27.
[24] 唐凤英,董汾,曾玉婷,等.miR-203a-3p通过ALOX15途径抑制胃癌细胞铁死亡[J].中南医学科学杂志,2022,50(6):796-800.
[25] Zhang H, Deng T, Liu R, et al.CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer[J].Mol Cancer, 2020,19(1):43.
[26] Shureiqi I, Wu Y, Chen D, et al.The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis[J].Cancer Res,2005,65(24):11486-11492.
[27] Shureiqi I, Chen D, Day RS, et al.Profiling lipoxygenase metabolism in specific steps of colorectal tumorigenesis[J].Cancer Prev Res (Phila),2010,3(7):829-838.
[28] Tian R, Zuo X, Jaoude J, et al.ALOX15 as a suppressor of inflammation and cancer: Lost in the link[J].Prostaglandins Other Lipid Mediat,2017,132:77-83.
[29] Liu F, Zuo X, Liu Y, et al.Suppression of membranous LRP5 recycling, Wnt/β-Catenin signaling, and colon carcinogenesis by 15-LOX-1 peroxidation of linoleic acid in PI3P[J].Cell Rep,2020,32(7):108049.
[30] Il Lee S, Zuo X, Shureiqi I.15-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in[J].Cancer Metastasis Rev,2011,30(3-4):481-491.
[31] Zuo X, Peng Z, Wu Y, et al.Effects of gut-targeted 15-LOX-1 transgene expression on colonic tumorigenesis in mice[J].J Natl Cancer Inst,2012,104(9):709-716.
[32] Moussalli MJ, Wu Y, Zuo X, et al.Mechanistic contribution of ubiquitous 15-lipoxygenase-1 expression loss in cancer cells to terminal cell differentiation evasion[J].Cancer Prev Res (Phila),2011,4(12):1961-1972.
[33] Na YJ, Kim BR, Kim JL, et al.Deficiency of 15-LOX-1 induces radioresistance through downregulation of MacroH2A2 in colorectal cancer[J].Cancers (Basel),2019,11(11):1776.
[34] Wang Y, Zhang Z, Sun W, et al.Ferroptosis in colorectal cancer: Potential mechanisms and effective therapeutic targets[J].Biomed Pharmacother,2022,153:113524.
[35] 陈伟鸿,苏小苹,苏宇超,等.铁死亡诱导剂在结直肠癌中的研究进展[J].中国医学创新,2023,20(34):180-184.
[36] 杨林,马翠,李非,等.15-脂氧合酶及其调控的信号通路在肿瘤中的作用[J].医学综述,2018,24(15):2995-3000.
[37] Kelavkar UP, Parwani AV, Shappell SB, et al.Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model[J].Neoplasia,2006,8(6):510-522.
[38] Hsi LC, Wilson LC, Eling TE.Opposing effects of 15-lipoxygenase-1 and -2 metabolites on MAPK signaling in prostate.Alteration in peroxisome proliferator-activated receptor gamma[J].J Biol Chem,2002,277(43):40549-40556.
[39] Hu Y, Sun H, O'Flaherty JT, et al.15-Lipoxygenase-1-mediated metabolism of docosahexaenoic acid is required for syndecan-1 signaling and apoptosis in prostate cancer cells[J].Carcinogenesis,2013,34(1):176-182.
[40] Liang J, Liao Y, Wang P, et al.Ferroptosis landscape in prostate cancer from molecular and metabolic perspective[J].Cell Death Discov,2023,9(1):128.
[41] Hosseinymehr M, Matin MM, Sadeghian H, et al.8-Farnesyloxycoumarin induces apoptosis in PC-3 prostate cancer cells by inhibition of 15-lipoxygenase-1 enzymatic activity[J].Anticancer Drugs,2016,27(9):854-862.
[42] Goftari SN, Sadeghian H, Bahrami AR, et al.Stylosin and some of its synthetic derivatives induce apoptosis in prostate cancer cells as 15-lipoxygenase enzyme inhibitors[J].Naunyn Schmiedebergs Arch Pharmacol,2019,392(12):1491-1502.
[43] Hassannia B, Vandenabeele P, Vanden Berghe T.Targeting ferroptosis to iron out cancer[J].Cancer Cell,2019,35(6):830-849.
[44] Mao C, Liu X, Zhang Y.DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer[J].Nature, 2021,593(7860):586-590.
